• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Oncocyte Corp (NQ: OCX )

    3.030 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.030
    Bid (Size) 1.220 (2)
    Ask (Size) 3.100 (50)
    Prev. Close 3.030
    Today's Range 3.030 - 3.030
    52wk Range 2.080 - 4.340
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
    OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
    Via AB Newswire

    Performance

    YTD
    -8.18%
    -8.18%
    1 Month
    +1.34%
    +1.34%
    3 Month
    -2.57%
    -2.57%
    6 Month
    +9.02%
    +9.02%
    1 Year
    +31.74%
    +31.74%

    More News

    Read More
    OncoCyte's Innovative Approach: Potential in Precision Diagnostics
    Via News Direct
    OncoCyte's Innovative Approach: Potential in Precision Diagnostics
    Via TheNewswire.com
    4 Analysts Assess OncoCyte: What You Need To Know
    Via Benzinga
    OncoCyte's Earnings: A Preview
    Via Benzinga
    Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
    Via ACCESSWIRE
    Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
    Via ACCESSWIRE
    OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    3 Penny Stocks That Insiders Are Buying
    Via MarketBeat
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
    Via ACCESSWIRE
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Top 3 Health Care Stocks That May Collapse In Q2
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Earnings Scheduled For April 12, 2024
    Via Benzinga
    Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.